anticonvulsants

Preferred Label : anticonvulsants;

MeSH definition : Drugs used to prevent SEIZURES or reduce their severity.;

MeSH synonym : anticonvulsant drugs; agents, anticonvulsive; anticonvulsive drugs; drugs, anticonvulsant; drugs, anticonvulsive; anticonvulsive agents; Anticonvulsive Agent; Agent, Anticonvulsive; Anticonvulsive Drug; Drug, Anticonvulsive; Anticonvulsant; Anticonvulsant Drug; Drug, Anticonvulsant;

Related MeSH term : antiepileptic agents; Agents, Antiepileptic; Antiepileptics; Antiepileptic Drugs; Drugs, Antiepileptic; Antiepileptic Drug; Drug, Antiepileptic; Antiepileptic; Antiepileptic Agent; Agent, Antiepileptic;

MeSH annotation : GEN or unspecified; prefer specifics; consider also CONVULSIONS /drug ther;

Wikipedia link : https://en.wikipedia.org/wiki/Anticonvulsant;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000927;

UMLS CUI

C0003286;

ATC code(s)
- cannabidiol [ATC Code]
ATC code(s)
- aminobutyric acid [ATC Code]
- anticholinergic agents [ATC Code]
- antiepileptics [ATC Code]
- antiepileptics [ATC Code]
- barbexaclone [ATC Code]
- barbiturates and derivatives [ATC Code]
- beclamide [ATC Code]
- benzodiazepine derivatives [ATC Code]
- carbamazepine [ATC Code]
- carisbamate [ATC Code]
- clonazepam [ATC Code]
- eslicarbazepine [ATC Code]
- ethosuximide, combinations [ATC Code]
- ethotoin [ATC Code]
- felbamate [ATC Code]
- fenfluramine [ATC Code]
- fosphenytoin [ATC Code]
- hydantoin derivatives [ATC Code]
- lacosamide [ATC Code]
- lamotrigine [ATC Code]
- levetiracetam [ATC Code]
- mephenytoin, combinations [ATC Code]
- mesuximide [ATC Code]
- metharbital [ATC Code]
- methylphenobarbital [ATC Code]
- other antiepileptics [ATC Code]
- oxazolidine derivatives [ATC Code]
- oxcarbazepine [ATC Code]
- phenacemide [ATC Code]
- pheneturide [ATC Code]
- phenobarbital [ATC Code]
- phensuximide [ATC Code]
- phenytoin [ATC Code]
- phenytoin, combinations [ATC Code]
- primidone [ATC Code]
- progabide [ATC Code]
- rufinamide [ATC Code]
- stiripentol [ATC Code]
- succinimide derivatives [ATC Code]
- sultiame [ATC Code]
- tiagabine [ATC Code]
- topiramate [ATC Code]
- trimethadione [ATC Code]
- valproic acid [ATC Code]
- valpromide [ATC Code]
- vigabatrin [ATC Code]
- zonisamide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- AC Regimen [NCIt concept]
- ASAH1 wt Allele [NCIt concept]
- Acetylcholine Measurement [NCIt concept]
- Achang Chinese [NCIt concept]
- Acid Ceramidase [NCIt concept]
- Acoli Language [NCIt concept]
- Acrocallosal syndrome [ORDO Disease]
- Active C5b6789 (substance) [SNOMED CT concept]
- Ameloblastic Carcinoma [NCIt concept]
- Anticonvulsant [ICHI extension code]
- Anticonvulsant level therapeutic (finding) [SNOMED CT concept]
- Antiepilepsy agent [ICHI extension code]
- Antiepileptics [ICD-11 Extension code]
- Before Meals [NCIt concept]
- Challenge Agent Characterization Domain [NCIt concept]
- Congenital analbuminemia (disorder) [SNOMED CT concept]
- Controlled by (attribute) [SNOMED CT concept]
- FGFR3 wt Allele [NCIt concept]
- Myoclonic-Atonic Epilepsy [NCIt concept]
- Myoclonic-astatic epilepsy [ORDO Disease]
- Myoclonic-atonic epilepsy [OMIM Phenotype]
- Other and unspecified antiepileptics [ICD-10 Sub-category (who)]
- Punctate inner choroidopathy (disorder) [SNOMED CT concept]
- other antiepileptics [ATC Code]
Currated CISMeF NLP mapping
- Anticonvulsant [ICD-11 Extension code]
- Anticonvulsant (substance) [SNOMED CT concept]
- Anticonvulsant Agent [NCIt concept]
- Anticonvulsants [LOINC component]
- anticonvulsant [Disease (Nov.)]
- anticonvulsant, nos [BNCI treatment]
- anticonvulsant, nos [SNOMED Notion]
- antiepileptics [ATC Code]
- antiepileptics [ATC Code]
Indexing information
- 1,3,5,5-trimethyl-2-cyclohexen-1-ylidine-2-propanone [MeSH Supplementary Concept]
- 2-(1-(4-chlorophenyl)-2-(1H-imidazol-1-yl)ethylidene)-N-p-tolylsemicarbazone [MeSH Supplementary Concept]
- 2-(methyl(3-phenylpropyl)amino)cyclohexanol [MeSH Supplementary Concept]
- 2-(methyl(phenethyl)amino)cyclohexanol [MeSH Supplementary Concept]
- 2-amino-5-ureidopentanamide [MeSH Supplementary Concept]
- 3-(4-fluorophenyl)-N-(4-bromophenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno(1,2-c)pyrazole-2-carboxamide [MeSH Supplementary Concept]
- 3-(pyridin-4-yl)-N-(4-chlorophenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno(1,2-c)pyrazole-2-carboxamide [MeSH Supplementary Concept]
- 4,5,6,7-tetrabromotriazole [MeSH Supplementary Concept]
- 4-(2-acetoxybenzoylamino)butyramide [MeSH Supplementary Concept]
- 4-chloro-N-(5-(((2-chloroquinolin-3-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)benzamide [MeSH Supplementary Concept]
- 4-chloro-N-(6-chloropyridin-3-yl)benzamide [MeSH Supplementary Concept]
- 6-(2,4-dichlorophenoxy)methyl-2H-(1,2,4)triazino(2,3-c)quinazolin-3(4H)-one [MeSH Supplementary Concept]
- 6-(3-(trifluoromethyl)benzyloxy)(1,2,4)triazolo(3,4-a)phthalazine [MeSH Supplementary Concept]
- 6-methoxy-2-((4-(benzyl)piperazin-1-yl)methyl)-9H-xanthen-9-one [MeSH Supplementary Concept]
- 9-carboxymethyl-4-oxo-imidazo(1,2-a)indeno-(1,2-e)pyrazin-2-carboxylic acid [MeSH Supplementary Concept]
- CID 56642816 [MeSH Supplementary Concept]
- N-((6-chloro-2,3-dihydrobenzo(1,4)dioxin-2-yl)methyl)sulfamide [MeSH Supplementary Concept]
- N-(2-(1-(4-chlorophenyl)-5-methoxy-1H-indole-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(1-(4-cyanobenzoyl)-5-methoxy-1H-indole-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(2,4-dichlorophenoxy)methyl-4-oxo-4H-quinazolin-3-yl)-2-((N'-pyridine-4-carbonyl)hydrazino)acetamide [MeSH Supplementary Concept]
- N-(5-(((2-chloroquinolin-3-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)-4-methylbenzamide [MeSH Supplementary Concept]
- N-(morpholinomethyl)-p-isopropoxyphenylsuccinimide [MeSH Supplementary Concept]
- N-hydroxymethyl-p-isopropoxyphenylsuccinimide [MeSH Supplementary Concept]
- N6-(3-methoxyl-4-hydroxybenzyl) adenine riboside [MeSH Supplementary Concept]
- SGE-102 [MeSH Supplementary Concept]
- cannabidivarin [MeSH Supplementary Concept]
- erysothrine [MeSH Supplementary Concept]
- eslicarbazepine [MeSH Supplementary Concept]
- ifenprodil [MeSH Supplementary Concept]
- licvorin [MeSH Supplementary Concept]
- parawixin 10, parawixia bistriata [MeSH Supplementary Concept]
- perampanel [MeSH Supplementary Concept]
- sec-butyl-propylacetamide [MeSH Supplementary Concept]
- urs-12-en-3-ol-28-oic acid 3-glucopyranosyl-4'-octadecanoate [MeSH Supplementary Concept]
- valnoctic acid [MeSH Supplementary Concept]
- vinpocetine [MeSH Supplementary Concept]
Record concept(s)
- anticonvulsants [MeSH concept]
- antiepileptic agents [MeSH concept]
See also
- barbiturates [MeSH Descriptor]
- seizures [MeSH Descriptor]
See also (suggested by CISMeF)
- epilepsy [MeSH Descriptor]
See also inter- (CISMeF)
- Medicinal product acting as anticonvulsant agent (product) [SNOMED CT concept]
- Other antiepileptics [ICD-11 Extension code]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,3-ditolylguanidine [MeSH Supplementary Concept]
- 1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one [MeSH Supplementary Concept]
- 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline [MeSH Supplementary Concept]
- 2,3-piperidinedicarboxylic acid [MeSH Supplementary Concept]
- 2-(2,3-dicarboxycyclopropyl)glycine [MeSH Supplementary Concept]
- 2-amino-4-methyl-5-phosphono-3-pentenoic acid [MeSH Supplementary Concept]
- 2-amino-4-phosphonobutyric acid [MeSH Supplementary Concept]
- 2-amino-7-phosphonoheptanoic acid [MeSH Supplementary Concept]
- 2-fluoro-2-phenyl-1,3-propanediyl dicarbamate [MeSH Supplementary Concept]
- 2-propyl-2-pentenoic acid [MeSH Supplementary Concept]
- 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid [MeSH Supplementary Concept]
- 4-amino-3-phenylbutyric acid [MeSH Supplementary Concept]
- 4-phenyl-perhydropyrrole(1,2-a)pyrazine-1,3-dione [MeSH Supplementary Concept]
- 5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate [MeSH Supplementary Concept]
- 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione [MeSH Supplementary Concept]
- 6-methoxytryptoline [MeSH Supplementary Concept]
- 7-nitroindazole [MeSH Supplementary Concept]
- CGP 39551 [MeSH Supplementary Concept]
- Cenobamate [MeSH Supplementary Concept]
- Clobazam [MeSH Descriptor]
- DN 1417 [MeSH Supplementary Concept]
- Felbamate [MeSH Descriptor]
- GYKI 52466 [MeSH Supplementary Concept]
- Gabapentin [MeSH Descriptor]
- L 701324 [MeSH Supplementary Concept]
- Lacosamide [MeSH Descriptor]
- Lamotrigine [MeSH Descriptor]
- Levetiracetam [MeSH Descriptor]
- N-(4,4-diphenyl-3-butenyl)nipecotic acid [MeSH Supplementary Concept]
- N-desmethylclobazam [MeSH Supplementary Concept]
- NCS 382 [MeSH Supplementary Concept]
- NNC 711 [MeSH Supplementary Concept]
- Oxcarbazepine [MeSH Descriptor]
- PD 117302 [MeSH Supplementary Concept]
- Pregabalin [MeSH Descriptor]
- Tiagabine [MeSH Descriptor]
- Topiramate [MeSH Descriptor]
- U 54494A [MeSH Supplementary Concept]
- ZK 91296 [MeSH Supplementary Concept]
- ZK 93423 [MeSH Supplementary Concept]
- ZK 93426 [MeSH Supplementary Concept]
- Zonisamide [MeSH Descriptor]
- abecarnil [MeSH Supplementary Concept]
- acetazolamide [MeSH Descriptor]
- alpha-hexachlorocyclohexane [MeSH Supplementary Concept]
- angelicin [MeSH Supplementary Concept]
- anthranilic acid [MeSH Supplementary Concept]
- bemethyl [MeSH Supplementary Concept]
- benzobarbital [MeSH Supplementary Concept]
- bretazenil [MeSH Supplementary Concept]
- brivaracetam [MeSH Supplementary Concept]
- bromides [MeSH Descriptor]
- cannabidiol [MeSH Descriptor]
- carbamazepine [MeSH Descriptor]
- chlordesmethyldiazepam [MeSH Supplementary Concept]
- chlormethiazole [MeSH Descriptor]
- clonazepam [MeSH Descriptor]
- clorazepate dipotassium [MeSH Descriptor]
- denzimol [MeSH Supplementary Concept]
- deramciclane [MeSH Supplementary Concept]
- diazepam [MeSH Descriptor]
- dimethadione [MeSH Descriptor]
- dipropylacetamide [MeSH Supplementary Concept]
- doramectin [MeSH Supplementary Concept]
- eperisone [MeSH Supplementary Concept]
- eslicarbazepine acetate [MeSH Supplementary Concept]
- estazolam [MeSH Descriptor]
- ethosuximide [MeSH Descriptor]
- ethotoin [MeSH Supplementary Concept]
- ethylphenylhydantoin [MeSH Supplementary Concept]
- ezogabine [MeSH Supplementary Concept]
- fludiazepam [MeSH Supplementary Concept]
- flunarizine [MeSH Descriptor]
- fosphenytoin [MeSH Supplementary Concept]
- gaboxadol [MeSH Supplementary Concept]
- gidazepam [MeSH Supplementary Concept]
- glutamic acid diethyl ester [MeSH Supplementary Concept]
- indeloxazine [MeSH Supplementary Concept]
- indol-3-yl pyruvic acid [MeSH Supplementary Concept]
- kavain [MeSH Supplementary Concept]
- lorazepam [MeSH Descriptor]
- loreclezole [MeSH Supplementary Concept]
- magnesium sulfate [MeSH Descriptor]
- mebeverine [MeSH Supplementary Concept]
- medazepam [MeSH Descriptor]
- mephenytoin [MeSH Descriptor]
- mephobarbital [MeSH Descriptor]
- meprobamate [MeSH Descriptor]
- methsuximide [MeSH Supplementary Concept]
- milacemide [MeSH Supplementary Concept]
- neo-kyotorphin [MeSH Supplementary Concept]
- neurotropin [MeSH Supplementary Concept]
- nimetazepam [MeSH Supplementary Concept]
- nitrazepam [MeSH Descriptor]
- org 2766 [MeSH Supplementary Concept]
- padsevonil [MeSH Supplementary Concept]
- paraldehyde [MeSH Descriptor]
- phenazepam [MeSH Supplementary Concept]
- pheneturide [MeSH Supplementary Concept]
- phenobarbital [MeSH Descriptor]
- phenytoin [MeSH Descriptor]
- pipequaline [MeSH Supplementary Concept]
- primidone [MeSH Descriptor]
- progabide [MeSH Supplementary Concept]
- progabide acid [MeSH Supplementary Concept]
- remacemide [MeSH Supplementary Concept]
- riluzole [MeSH Descriptor]
- rimcazole [MeSH Supplementary Concept]
- rufinamide [MeSH Supplementary Concept]
- ryodipine [MeSH Supplementary Concept]
- sidnocarb [MeSH Supplementary Concept]
- stiripentol [MeSH Supplementary Concept]
- sulthiame [MeSH Supplementary Concept]
- taglutimide [MeSH Supplementary Concept]
- thiopental [MeSH Descriptor]
- thioperamide [MeSH Supplementary Concept]
- tiletamine [MeSH Descriptor]
- tizanidine [MeSH Supplementary Concept]
- tramiprosate [MeSH Supplementary Concept]
- trimethadione [MeSH Descriptor]
- valproic acid [MeSH Descriptor]
- vanillin [MeSH Supplementary Concept]
- vigabatrin [MeSH Descriptor]
- zaleplon [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anticonvulsant [ICD-11 Extension code]
- Anticonvulsant (substance) [SNOMED CT concept]
- Anticonvulsant Agent [NCIt concept]
- Anticonvulsants [LOINC component]
- Medicinal product acting as anticonvulsant agent (product) [SNOMED CT concept]
- anticonvulsant, nos [BNCI treatment]
- anticonvulsant, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients